NAYA Biosciences to Present GPC3-Targeting NK Engager Data at SITC
31 Oct 2024 //
GLOBENEWSWIRE
NAYA Biosciences Initiates Phase 1/2a Trial For GPC3 NK Engager
24 Oct 2024 //
GLOBENEWSWIRE
Invo Bio Confirms Name Change And New Trading Symbol Post-Merger
21 Oct 2024 //
GLOBENEWSWIRE
Invo And Naya Biosciences Close Merger, Combined to Operate as Naya
14 Oct 2024 //
GLOBENEWSWIRE
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for LHON
23 Jan 2024 //
GLOBENEWSWIRE
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements
17 Jan 2024 //
GLOBENEWSWIRE
ONK Therapeutics and NAYA Biosciences Announce Research Partnership
06 Dec 2023 //
GLOBENEWSWIRE